UK-224671

Details

Stereochemistry	ABSOLUTE
Molecular Formula	C25H36Cl2N4O3S
Molecular Weight	543.549
Optical Activity	UNSPECIFIED
Defined Stereocenters	1 / 1
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

CS(=O)(=O)N1CCN(CC1)C2CN(CC[C@@]3(CCC(=O)N(CC4CC4)C3)C5=CC(Cl)=C(Cl)C=C5)C2

InChI

InChIKey=YZMQJVWDZXNEBA-RUZDIDTESA-N

InChI=1S/C25H36Cl2N4O3S/c1-35(33,34)31-12-10-29(11-13-31)21-16-28(17-21)9-8-25(20-4-5-22(26)23(27)14-20)7-6-24(32)30(18-25)15-19-2-3-19/h4-5,14,19,21H,2-3,6-13,15-18H2,1H3/t25-/m1/s1

HIDE SMILES / InChI

Molecular Formula	C25H36Cl2N4O3S
Molecular Weight	543.549
Charge	0
Count

Stereochemistry	ABSOLUTE
Additional Stereochemistry	No
Defined Stereocenters	1 / 1
E/Z Centers	0
Optical Activity	UNSPECIFIED

Approval Year

Substance Class	Chemical Created by `admin` on `Wed Apr 02 20:48:04 GMT 2025` Edited by `admin` on `Wed Apr 02 20:48:04 GMT 2025`
Record UNII	V7M68E8XRC
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

UK-224671

Code

English

UK-224,671

Preferred Name

English

(5S)-1-(Cyclopropylmethyl)-5-(3,4-dichlorophenyl)-5-[2-[3-(4-methylsulfonylpiperazin-1-yl)azetidin-1-yl]ethyl]piperidin-2-one

Systematic Name

English

1-[1-[2-[(3S)-1-(Cyclopropylmethyl)-3-(3,4-dichlorophenyl)-6-oxo-3-piperidinyl]ethyl]-3-azetidinyl]-4-(methylsulfonyl)piperazine

Common Name

English

Piperazine, 1-[1-[2-[(3S)-1-(cyclopropylmethyl)-3-(3,4-dichlorophenyl)-6-oxo-3-piperidinyl]ethyl]-3-azetidinyl]-4-(methylsulfonyl)-

Systematic Name

English

Code System Code Type Description

PUBCHEM

9807403

Created by admin on Wed Apr 02 20:48:04 GMT 2025 , Edited by admin on Wed Apr 02 20:48:04 GMT 2025

PRIMARY

FDA UNII

V7M68E8XRC

Created by admin on Wed Apr 02 20:48:04 GMT 2025 , Edited by admin on Wed Apr 02 20:48:04 GMT 2025

PRIMARY

CAS

178309-91-6

Created by admin on Wed Apr 02 20:48:04 GMT 2025 , Edited by admin on Wed Apr 02 20:48:04 GMT 2025

PRIMARY

Related Record Type Details


					2K524Y8G0J

BLOOD CELLS, RED

BINDER->LIGAND

Comments:

Distributed preferentially into the red cell fraction inblood with most extensive distribution into human red cells

Amount:


					79AAW649HW

SUBSTANCE-K RECEPTOR

TARGET -> INHIBITOR

Amount:


					6D53G0FD0Z

PLASMA PROTEIN FRACTION (HUMAN)

BINDER->LIGAND

Interaction Type:

BINDING

Amount:


					V7M68E8XRC

UK-224671

EXCRETED UNCHANGED

Qualification:

URINE

Amount:

Related Record Type Details


					V7M68E8XRC

UK-224671

ACTIVE MOIETY

Comments:

Treatment of urinary incontinence.

Amount:

Name	Property Type	Parameters
Volume of Distribution	PHARMACOKINETIC
log D	CHEMICAL	pH CHEMICAL
Biological Half-life	PHARMACOKINETIC